These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38744076)
1. pH-responsive drug-loaded peptides enhance drug accumulation and promote apoptosis in tumor cells. Gong Z; Zhao H; Bai J Colloids Surf B Biointerfaces; 2024 Jul; 239():113954. PubMed ID: 38744076 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting. Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983 [TBL] [Abstract][Full Text] [Related]
3. Targeted drug-loaded peptides induce tumor cell apoptosis and immunomodulation to increase antitumor efficacy. Li H; Zhang P; Yuan X; Peng S; Yang X; Li Y; Shen Z; Bai J Biomater Adv; 2024 Jun; 160():213852. PubMed ID: 38636118 [TBL] [Abstract][Full Text] [Related]
4. A dual drug-loaded peptide system with morphological transformation prolongs drug retention and inhibits breast cancer growth. Zhai X; Tang S; Meng F; Ma J; Li A; Zou X; Zhou B; Peng F; Bai J Biomater Adv; 2023 Nov; 154():213650. PubMed ID: 37857084 [TBL] [Abstract][Full Text] [Related]
5. pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy. Shin JY; Yang Y; Heo P; Lee JC; Kong B; Cho JY; Yoon K; Shin CS; Seo JH; Kim SG; Kweon DH Int J Nanomedicine; 2012; 7():2805-16. PubMed ID: 22745543 [TBL] [Abstract][Full Text] [Related]
6. pH-Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy. Yuan X; Liu X; Li H; Peng S; Huang H; Yu Z; Chen L; Liu X; Bai J Adv Healthc Mater; 2024 Jul; 13(18):e2400031. PubMed ID: 38588449 [TBL] [Abstract][Full Text] [Related]
7. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis. Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119 [TBL] [Abstract][Full Text] [Related]
8. Reduction-Triggered Paclitaxel Release Nano-Hybrid System Based on Core-Crosslinked Polymer Dots with a pH-Responsive Shell-Cleavable Colorimetric Biosensor. Kim SG; Ryplida B; Phuong PTM; Won HJ; Lee G; Bhang SH; Park SY Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661903 [TBL] [Abstract][Full Text] [Related]
9. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells. Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461 [TBL] [Abstract][Full Text] [Related]
10. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells. Muhammad N; Zhao H; Song W; Gu M; Li Q; Liu Y; Li C; Wang J; Zhan H Nanotechnology; 2021 Feb; 32(8):085105. PubMed ID: 33197899 [TBL] [Abstract][Full Text] [Related]
11. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor. Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Li Y; Hou H; Zhang P; Zhang Z Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576 [TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. Yang X; Cai X; Yu A; Xi Y; Zhai G J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749 [TBL] [Abstract][Full Text] [Related]
14. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation. Levit SL; Gade NR; Roper TD; Yang H; Tang C Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475 [TBL] [Abstract][Full Text] [Related]
15. l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells. Niu S; Bremner DH; Wu J; Wu J; Wang H; Li H; Qian Q; Zheng H; Zhu L Drug Deliv; 2018 Nov; 25(1):1275-1288. PubMed ID: 29847177 [TBL] [Abstract][Full Text] [Related]
17. The programmed site-specific delivery of the angiostatin sunitinib and chemotherapeutic paclitaxel for highly efficient tumor treatment. He J; Xiao H; Li B; Peng Y; Li X; Wang Y; Adamus G; Kowalczuk M; Shuai X J Mater Chem B; 2019 Aug; 7(32):4953-4962. PubMed ID: 31411627 [TBL] [Abstract][Full Text] [Related]
18. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates. Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464 [No Abstract] [Full Text] [Related]
19. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
20. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]